Chih‐Lang Lin

1.5k total citations
87 papers, 921 citations indexed

About

Chih‐Lang Lin is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Chih‐Lang Lin has authored 87 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Epidemiology, 55 papers in Hepatology and 12 papers in Surgery. Recurrent topics in Chih‐Lang Lin's work include Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (39 papers) and Hepatitis B Virus Studies (38 papers). Chih‐Lang Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (39 papers) and Hepatitis B Virus Studies (38 papers). Chih‐Lang Lin collaborates with scholars based in Taiwan, United States and South Korea. Chih‐Lang Lin's co-authors include Rong‐Nan Chien, Chau‐Ting Yeh, Cheng‐Hung Chien, Li‐Wei Chen, Tsung‐Hui Hu, Kung‐Hao Liang, Yi‐Cheng Chen, Sheng‐Fong Kuo, Yu‐Chiau Shyu and Ching‐Chih Hu and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Chih‐Lang Lin

82 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chih‐Lang Lin Taiwan	17	498	432	146	111	101	87	921
Yoshihiro Kanbara Japan	13	436 0.9×	297 0.7×	111 0.8×	144 1.3×	53 0.5×	30	739
Tomomi Kogiso Japan	19	731 1.5×	448 1.0×	215 1.5×	195 1.8×	75 0.7×	74	1.0k
Hongqin Xu China	18	510 1.0×	338 0.8×	89 0.6×	194 1.7×	35 0.3×	46	885
Xiaoping Wu China	11	217 0.4×	345 0.8×	226 1.5×	99 0.9×	57 0.6×	29	735
Kazunori Ishige Japan	14	238 0.5×	120 0.3×	175 1.2×	187 1.7×	120 1.2×	34	639
Shiying Xuan China	20	1.3k 2.6×	907 2.1×	283 1.9×	171 1.5×	110 1.1×	58	1.7k
Kuei‐Chuan Lee Taiwan	17	325 0.7×	277 0.6×	108 0.7×	87 0.8×	49 0.5×	35	605
Yoichiro Kitajima Japan	16	672 1.3×	308 0.7×	171 1.2×	216 1.9×	353 3.5×	25	1.2k
T Kashiwagi Japan	18	304 0.6×	545 1.3×	355 2.4×	109 1.0×	123 1.2×	60	928
Ming‐Chih Hou Taiwan	23	802 1.6×	994 2.3×	615 4.2×	114 1.0×	54 0.5×	105	1.5k

Countries citing papers authored by Chih‐Lang Lin

Since Specialization

Citations

This map shows the geographic impact of Chih‐Lang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Lang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Lang Lin more than expected).

Fields of papers citing papers by Chih‐Lang Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Lang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Lang Lin. The network helps show where Chih‐Lang Lin may publish in the future.

Co-authorship network of co-authors of Chih‐Lang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Lang Lin. A scholar is included among the top collaborators of Chih‐Lang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Lang Lin. Chih‐Lang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soong, Ruey‐Shyang, et al.. (2025). SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes. Diabetes & Metabolism. 51(6). 101698–101698.

Lin, Chih‐Lang, et al.. (2023). Patients with Non-Alcoholic Fatty Liver Disease and Alcohol Dehydrogenase 1B/Aldehyde Dehydrogenase 2 Mutant Gene Have Higher Values of Serum Alanine Transaminase. Journal of Personalized Medicine. 13(5). 758–758. 6 indexed citations

Lin, Chih‐Lang, et al.. (2023). The Protective Effect of Vitamin D on Dementia Risk in Hemodialysis Patients. Life. 13(8). 1741–1741. 3 indexed citations

Lin, Chih‐Lang, Szu‐Yuan Wu, Ming‐Wei Lai, et al.. (2023). Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy. Cancers. 15(13). 3343–3343. 2 indexed citations

Jeng, Wen‐Juei, Rong‐Nan Chien, Yi‐Cheng Chen, et al.. (2023). Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis. Hepatology. 79(3). 690–703. 15 indexed citations

Lin, Chih‐Lang, Wan‐Ming Chen, Ben‐Chang Shia, & Szu‐Yuan Wu. (2023). Statin use and its association with decreased risk of esophageal squamous cell carcinoma in betel nut chewers. Thoracic Cancer. 14(23). 2241–2250. 2 indexed citations

Lin, Chih‐Lang, Kung‐Hao Liang, Ching‐Chih Hu, et al.. (2023). A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24(2). 1681–1681. 1 indexed citations

Wang, Liang‐Jen, Chih‐Lang Lin, Yi‐Chih Chen, et al.. (2022). Sex Differences in the Relationship between Excessive Alcohol Consumption and Metabolic Abnormalities: A Community-Based Study in Taiwan. Nutrients. 14(14). 2957–2957. 3 indexed citations

Chen, Wei‐Ting, Shi‐Ming Lin, Wei‐Chen Lee, et al.. (2022). GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology International. 16(1). 148–158. 11 indexed citations

10.

Tsai, Ming‐Chao, Chun‐Yen Lin, Chien‐Hung Chen, et al.. (2020). Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment. PLoS ONE. 15(4). e0231102–e0231102. 11 indexed citations

11.

Lin, Chih‐Lang, Chao‐Wei Hsu, Ming‐Ling Chang, et al.. (2019). Decreasing seroprevalence of anti‐hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019. Journal of Medical Virology. 92(1). 124–127. 3 indexed citations

12.

Shyu, Yu‐Chiau, Ting Huang, Cheng‐Hung Chien, et al.. (2019). Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population‐based cohort study. Journal of Viral Hepatitis. 26(6). 718–726. 28 indexed citations

13.

Liang, Kung‐Hao, Peng Zhang, Chih‐Lang Lin, et al.. (2019). Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients. Digestive Diseases and Sciences. 65(7). 2130–2139. 10 indexed citations

14.

Hu, Ching‐Chih, Cheng‐Hung Chien, Li‐Wei Chen, et al.. (2019). The Defective Allele of Aldehyde Dehydrogenase 2 Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular Carcinoma. Journal of Cancer. 10(23). 5735–5743. 13 indexed citations

15.

Hu, Ching‐Chih, Cheng‐Hao Weng, Man‐Chin Hua, et al.. (2019). New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy. Journal of Interferon & Cytokine Research. 40(2). 82–91. 5 indexed citations

16.

Lin, Chen‐Chun, Chao‐Wei Hsu, Yi‐Cheng Chen, et al.. (2019). A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy. The Pharmacogenomics Journal. 20(1). 57–68. 10 indexed citations

17.

Lai, Ming‐Wei, Chao‐Wei Hsu, Chih‐Lang Lin, et al.. (2018). Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study. Hepatology International. 12(5). 456–464. 12 indexed citations

18.

Hu, Ching‐Chih, Cheng‐Hao Weng, Liang‐Che Chang, et al.. (2018). Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy. Therapeutics and Clinical Risk Management. Volume 14. 783–791. 2 indexed citations

19.

Chien, Cheng‐Hung, et al.. (2015). Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy. Journal of Interferon & Cytokine Research. 35(12). 981–989. 12 indexed citations

20.

Hu, Ching‐Chih, et al.. (2013). Thrombocytopenia as a Strong Indicator of Liver Fibrosis in Chronic Liver Disease Patients from Areas Hyperendemic for Hepatitis B and C Virus Infection. 30(4). 290–299. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact